Journal of Clinical Endocrinology & Metabolism, Vol 55, 983-988, Copyright © 1982 by Endocrine Society

ARTICLES

Phosphodiesterase activity in human subcutaneous adipose tissue in insulin- and noninsulin-dependent diabetes mellitus

P Engfeldt, P Arner, J Bolinder and J Ostman

The influence of diabetes mellitus on phosphodiesterase (PDE) activity in human sc adipose tissue was investigated in 8 patients with insulin- dependent (IDDM) and 9 with noninsulin-dependent (NIDDM) diabetes mellitus. The results were compared with data from 10 healthy normal weight subjects. The apparent maximal PDE activity (Vmax) of the low Km form of PDE was 60% lower (P less than 0.01) in untreated IDDM and NIDDM than in the control state. After treatment of IDDM and NIDDM, the Vmax of the low Km PDE was normalized. In untreated IDDM and NIDDM, the Vmax of the low Km PDE was correlated to the cAMP level (r = 0.8). This correlation was not observed after antidiabetic treatment or in the control state. The apparent Vmax values of the high Km form of PDE were similar in the diabetic states and in control subjects. The results suggest that the low Km PDE is inhibited in untreated IDDM and NIDDM. In these conditions, PDE may be one factor responsible for regulation of the cAMP level.

This article has been cited by other articles:

				H. Ying, O. Araki, F. Furuya, Y. Kato, and S.-Y. Cheng Impaired Adipogenesis Caused by a Mutated Thyroid Hormone {alpha}1 Receptor Mol. Cell. Biol., March 15, 2007; 27(6): 2359 - 2371. [Abstract] [Full Text] [PDF]

				T. Fujimura, C. Kimura, T. Oe, Y. Takata, H. Sakuma, I. Aramori, and S. Mutoh A Selective Peroxisome Proliferator-Activated Receptor {gamma} Modulator with Distinct Fat Cell Regulation Properties J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 863 - 871. [Abstract] [Full Text] [PDF]

				E. A. Medina, R. R. Afsari, T. Ravid, S. S. Castillo, K. L. Erickson, and T. Goldkorn Tumor Necrosis Factor-{alpha} Decreases Akt Protein Levels in 3T3-L1 Adipocytes via the Caspase-Dependent Ubiquitination of Akt Endocrinology, June 1, 2005; 146(6): 2726 - 2735. [Abstract] [Full Text] [PDF]

				L. Harndahl, N. Wierup, S. Enerback, H. Mulder, V. C. Manganiello, F. Sundler, E. Degerman, B. Ahren, and L. S. Holst {beta}-Cell-targeted Overexpression of Phosphodiesterase 3B in Mice Causes Impaired Insulin Secretion, Glucose Intolerance, and Deranged Islet Morphology J. Biol. Chem., April 9, 2004; 279(15): 15214 - 15222. [Abstract] [Full Text] [PDF]

				J. Mei, L. S. Holst, T. R. Landstrom, C. Holm, D. Brindley, V. Manganiello, and E. Degerman C2-Ceramide Influences the Expression and Insulin-Mediated Regulation of Cyclic Nucleotide Phosphodiesterase 3B and Lipolysis in 3T3-L1 Adipocytes Diabetes, March 1, 2002; 51(3): 631 - 637. [Abstract] [Full Text] [PDF]

				U. Smith Thiazolidinedione-induced effects beyond glycaemic control The British Journal of Diabetes & Vascular Disease, January 1, 2002; 2(1_suppl): S24 - S27. [Abstract] [PDF]